Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs sevoflurane for anesthesia induction with preserved spontaneous breathing during endotracheal intubation
ChiCTR2100048242Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Success rate of intubation induced by anesthesia with spontaneous breathing. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100048242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048242.